Tramadol Administered Orally to Healthy Subjects for the Improvement of its Detection in Biological Matrices in the Context of Anti-Doping Control
Phase 1
Recruiting
- Conditions
- healthy subjectsMedDRA version: 21.0Level: LLTClassification code: 10076471Term: Drug doping Class: 10022117Therapeutic area: Phenomena and Processes [G] - Metabolism [G03]
- Registration Number
- CTIS2023-503799-25-00
- Lead Sponsor
- Parc De Salut Mar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: ;Secondary Objective: ;Primary end point(s):
- Secondary Outcome Measures
Name Time Method